Market Place
Sourcing Support
Chongqing Xingtaihao Announces For API Line Upgrade Completion
04 Nov 2024 //
PRESS RELEASE
Chongqing Pharma Seeks Public Input On Peptide API Plant Study
04 Nov 2024 //
PRESS RELEASE
Huashan Sword Contest Xingtaihao invites you to compete in skills
27 Sep 2024 //
PRESS RELEASE
Xingtaihao listed as National Innovation "little giant"enterprise
10 Sep 2024 //
PRESS RELEASE
Xingtaihao, the only approved pharmaceutical company in the city
05 Aug 2024 //
PRESS RELEASE
Kangfude Secures 120M RMB, Partners With Desano For Peptide Commerce Platform
24 Jul 2024 //
PRESS RELEASE
Chongqing Xingtaihao Releases 2024 Environmental Emergency Response Plan
11 Jul 2024 //
PRESS RELEASE
Chongqing Xingtaihao Releases Second Public Notice For Semaglutide API Line EIA
27 May 2024 //
PRESS RELEASE
Xingtaihao Hao Pharma & Shijian Bio Form Strategic Partnership In ADC Field
13 May 2024 //
PRESS RELEASE
Chongqing Xingtaihao API Line Upgrade Pre-Approval EIA Public Notice Issued
15 Jan 2024 //
PRESS RELEASE
Chongqing Xingtaihao Celebrates 20th Anniversary
09 Jan 2024 //
PRESS RELEASE
Second Public Input Announcement Impact Assessment Chongqing Xingtaihao API Synthesis Line EIA
18 Dec 2023 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.